Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chi-Long Chen

Showing results (131-140 of 135) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 135 results.
Biomarker Research|August 8, 2025
Correction: Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patientsTzu-Chun Cheng, Mien-Chie Hung, Lu-Hai Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2019
Signaling pathway of globo-series glycosphingolipids and β1,3-galactosyltransferase V (β3GalT5) in breast cancerPo-Kai Chuang, Michael Hsiao, Tsui-Ling Hsu, et al.
Frontiers in Endocrinology|April 27, 2019
Corrigendum: Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different <i>K-RAS</i> StatusYu-Tang Chin, Zong-Rong He, Chi-Long Chen, et al.
Elife|March 18, 2016
The nucleolar protein NIFK promotes cancer progression via CK1α/β-catenin in metastasis and Ki-67-dependent cell proliferationTsung-Chieh Lin, Chia-Yi Su, Pei-Yu Wu, et al.
Cancers|April 3, 2021
High-Grade B-Cell Lymphoma (HGBL) with <i>MYC</i> and <i>BCL2</i> and/or <i>BCL6</i> Rearrangements Is Predominantly BCL6-Rearranged and BCL6-Expressing in TaiwanCheng-Chih Tsai, Yung-Cheng Su, Oluwaseun Adebayo Bamodu, et al.
Pageof 14

Showing results (131-140 of 135) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 135 results.
Biomarker Research|August 8, 2025
Correction: Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patientsTzu-Chun Cheng, Mien-Chie Hung, Lu-Hai Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2019
Signaling pathway of globo-series glycosphingolipids and β1,3-galactosyltransferase V (β3GalT5) in breast cancerPo-Kai Chuang, Michael Hsiao, Tsui-Ling Hsu, et al.
Frontiers in Endocrinology|April 27, 2019
Corrigendum: Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different <i>K-RAS</i> StatusYu-Tang Chin, Zong-Rong He, Chi-Long Chen, et al.
Elife|March 18, 2016
The nucleolar protein NIFK promotes cancer progression via CK1α/β-catenin in metastasis and Ki-67-dependent cell proliferationTsung-Chieh Lin, Chia-Yi Su, Pei-Yu Wu, et al.
Cancers|April 3, 2021
High-Grade B-Cell Lymphoma (HGBL) with <i>MYC</i> and <i>BCL2</i> and/or <i>BCL6</i> Rearrangements Is Predominantly BCL6-Rearranged and BCL6-Expressing in TaiwanCheng-Chih Tsai, Yung-Cheng Su, Oluwaseun Adebayo Bamodu, et al.
Pageof 14